Back to Search
Start Over
Update on tolterodine extended-release for treatment of overactive bladder
- Source :
- Open Access Journal of Urology, Vol 2010, Iss default, Pp 185-191 (2010), Open Access Journal of Urology
- Publication Year :
- 2010
- Publisher :
- Dove Medical Press, 2010.
-
Abstract
- Tola Omotosho, Chi Chiung Grace ChenWomen’s Center for Pelvic Health, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USAAbstract: Overactive bladder is a prevalent condition which negatively impacts quality of life and puts a significant economical burden on society. First-line therapy often includes pharmacotherapy with antimuscarinic medications, and numerous research studies have demonstrated that tolterodine extended-release (ER) is an efficacious and tolerable formulation of this class of medication. This review provides an update on the clinical use of tolterodine ER, detailing the current literature on its efficacy, tolerability, adverse effects, and comparability with other commonly prescribed medications for the treatment of overactive bladder.Keywords: antimuscarinics, efficacy, quality of life, overactive bladder, tolterodine, urgency, urge urinary incontinence
- Subjects :
- medicine.medical_specialty
lcsh:Internal medicine
DOAJ:Medicine (General)
lcsh:Specialties of internal medicine
Urology
efficacy
lcsh:Medicine
Review
lcsh:RC870-923
urgency
Pharmacotherapy
Quality of life
lcsh:RC581-951
medicine
DOAJ:Urology
Adverse effect
Intensive care medicine
lcsh:RC31-1245
antimuscarinics
business.industry
lcsh:R
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
tolterodine
Tolerability
Overactive bladder
quality of life
urge urinary incontinence
Research studies
overactive bladder
Tolterodine
Extended release
business
DOAJ:Health Sciences
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 11791551
- Volume :
- 2010
- Database :
- OpenAIRE
- Journal :
- Open Access Journal of Urology
- Accession number :
- edsair.doi.dedup.....826a87b9f1459c62ebc2f978180fd23b